Devices & Diagnostics, Policy

Medtronic’s busy day at the U.S. Supreme Court

The U.S. Supreme Court has decided to reject a Medtronic (MDT) appeal and leave the Edwards Lifesciences […]

The U.S. Supreme Court has decided to reject a Medtronic (MDT) appeal and leave the Edwards Lifesciences (EW) valve patent intact, which stands to lose Medtronic as much as $200 million, Bloomberg reports. The medical device company has received a big blow in its battle with Edwards Lifesciences, but the court may hear its arguments against a patient-plaintiff.

The court also has reached out to the Obama administration for advice concerning Medtronic v. Stengel, the patient left paraplegic after surgeons implanted the SynchroMed EL pump and catheter. Medtronic will argue on the grounds not that Stengel is incorrect about the cause of his paralysis (or that the company knew about the risks of the device), but instead that Stengel “can’t use state law to sue device makers for allegedly violating a duty under federal law.”

Shares0
Shares0